Use of antiherpes drugs and the risk of Kaposi's sarcoma: Data from the multicenter AIDS Cohort Study

Journal of Infectious Diseases

Volumn 173, Issue 6, 1996, Pages 1477-1480

  Glesby, Marshall J ^a   Hoover, Donald R ^b   Weng, Shigui ^b   Graham, Neil M H ^b   Phair, John P ^b   Detels, Roger ^b   Ho, Monto ^b   Saah, Alfred J ^b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; FOSCARNET; GANCICLOVIR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CANCER RISK; CASE CONTROL STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; HERPES; HOMOSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KAPOSI SARCOMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK ASSESSMENT;

EID: 0029843883     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/173.6.1477     Document Type: Article

References (15)

1. Beral V, Peterman TA, Berkelman RL, Jaffe HW. Kaposi's sarcoma among persons with AIDS: a sexually transmitted infection? Lancet 1990;335:123-8.
2. Jacobson LP, Muñoz A, Fox R, et al. Incidence of Kaposi's sarcoma in a cohort of homosexual men infected with the human immunodeficiency virus type 1. J Acquir Immune Defic Syndr 1990;3(suppl 1):S24-31.
3. Chang Y, Cesarman E, Pessin MS, et al. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 1994;266:1865-9.
4. Moore PS, Chang Y. Detection of herpesvirus-like DNA sequences in Kaposi's sarcoma in patients with and without HIV infection. N Engl J Med 1995;332:1181-5.
5. Huang YQ, Li JJ, Kaplan MH, et al. Human herpesvirus-like nucleic acid in various forms of Kaposi's sarcoma. Lancet 1995;345:759-61.
6. Kaslow RA, Ostrow DG, Detels R, et al. The Multicenter AIDS Cohort Study: rationale, organization, and selected characteristics of the participants. Am J Epidemiol 1987;126:310-8.
7. Centers for Disease Control. Revision of the CDC surveillance case definition for acquired immune deficiency syndrome. MMWR 1987;36:1S15S.
8. Stein DS, Graham NMH, Park LP, et al. The effect of the interaction of acyclovir with zidovudine on progression to AIDS and survival: analysis of data in the Multicenter AIDS Cohort Study. Ann Intern Med 1994; 100-8.
9. Armenian HK, Hoover DR, Rubb S, et al. Composite risk score for Kaposi's sarcoma based on a case-control and longitudinal study in the Multicenter AIDS Cohort Study (MACS) population. Am J Epidemiol 1993;138:256-65.
10. Cox DR. Regression models and life tables. J R Stat Soc 1972;34:187-220.
11. Hamilton JD, Hartigan PM, Simberkoff MS, et al. A controlled trial of early versus late treatment with zidovudine in symptomatic human immunodeficiency virus infection: results of the Veterans Affairs Cooperative Study. N Engl J Med 1992;437-43.
12. Hoover DR, Black C, Jacobson LP, et al. Epidemiologic analysis of Kaposi's sarcoma as an early and later AIDS outcome in homosexual men. Am J Epidemiol 1993;138:266-78.
13. Colby BM, Shaw JE, Elion GB, Pagano JS. Effect of acyclovir [9-(2hydroxyethoxymethyl)guanine] on Epstein-Barr virus DNA replication. J Virol 1980;34:560-8.
14. Jones JL, Hanson DL, Chu SY, Ward JW, Jaffe HW. AIDS-associated Kaposi's sarcoma [letter]. Science 1995;267:1078-9.
15. Morfeldt L, Torssander J. Long-term remission of Kaposi's sarcoma following foscarnet treatment in HIV-infected patients. Scand J Infect Dis 1994:26:749-52.